Table 3a.

Clinical characteristics associated with risk of gram-positive cocci infection among MRSA-colonized neonates eligible for mupirocin treatment (Analysis 1)

Variable	HR	95% CI	aHR	95% CI
mupirocin treatment	0.43	0.21–0.86	0.36	0.17–0.76
LOS prior to study entry (days)	0.99	0.98–1.01	0.98	0.97–1.00
Calendar year	0.94	0.80–1.10	1.00	0.85–1.18
Previous gram-positive cocci in culture	1.03	0.47–2.26	0.93	0.40–2.17
Birth weight (g)	1.00	0.99–1.00	1.00	0.99–1.00
Gestational age (weeks)	0.94	0.88–1.02	0.89	0.76–1.02
Site
Site 1	0.86	0.45–1.65	0.72	0.30–1.72
Site 2	0.79	0.38–1.64	0.79	0.24–2.58
Site 3 (Ref)	-	-	-	-